| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| pmid25991433-compound-a1 | cyclin-dependent kinase 1 | NA | Clinical trial target | TTD , DGIDB | NA | NA | patented | unknown |
| pmid25991433-compound-a1 | cyclin-dependent kinase 2 | NA | Clinical trial target | TTD , DGIDB | NA | NA | patented | unknown |
| pmid25991433-compound-a1 | cyclin-dependent kinase 4 | NA | Successful target | TTD , DGIDB | NA | NA | patented | unknown |
| pmid25991433-compound-a1 | stress-activated protein kinase jnk3 | NA | Patented-recorded target | TTD , DGIDB | NA | NA | patented | unknown |
| pmid25991433-compound-a1 | stress-activated protein kinase 2a | NA | Clinical trial target | TTD , DGIDB | NA | NA | patented | unknown |
| pmid25991433-compound-a1 | stress-activated protein kinase jnk1 | NA | Clinical trial target | TTD , DGIDB | NA | NA | patented | unknown |
| pmid25991433-compound-a1 | stress-activated protein kinase jnk2 | NA | Preclinical target | TTD , DGIDB | NA | NA | patented | unknown |
| click here to return to the previous page | ||||||||